Skip to main content

Advertisement

SpringerLink
Log in

Neurokinin-2-Rezeptorantagonist

Neue Hoffnung auf eine effektive Therapie des Reizdarmsyndroms mit Diarrhö

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  • Tack J et al. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS. Gut 2017; 66: 1403 – 13

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renatatstr. 50, 80639, München, Deutschland

    Hermann S. Füeßl (Internist — Gastroenterologe, Privatpraxis für Integrative Innere Medizin)

Authors
  1. Hermann S. Füeßl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hermann S. Füeßl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Füeßl, H.S. Neue Hoffnung auf eine effektive Therapie des Reizdarmsyndroms mit Diarrhö. Gastro-News 4, 11–12 (2017). https://doi.org/10.1007/s15036-017-0267-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-017-0267-0

Search

Navigation